To the best of our knowledge, this is the first report directly evaluated FOXO1 and FOXO3A expression along with inflammatory gene expression and metal analysis in the serum of obesity, depression, diabetic type II and NDs simultaneously. This evidence concerns the gene FOXO1 and type 2 diabetes mellitus.